EASE (Equity Award Scheme for Employees) is a standard ESOP scheme for Indian private limited companies. Every clause is public, so your lawyer, your investors and your team can read exactly what you are adopting.
The scheme text is published under the Creative Commons Attribution-NoDerivatives 4.0 licence (CC BY-ND 4.0). In plain English:
[Company name]
(CIN: [CIN])
EASE
(Equity Award Scheme for Employees)
THIS SCHEME has been formulated by the Board of Directors of [Company name], a company incorporated in India under the Companies Act, 2013, bearing CIN [CIN], with its registered office at [Registered office address] (the “Company”), and adopted by a special resolution of the shareholders dated , to grant Employee Stock Options to eligible employees of the Company, subject to the terms set out below. Amendments to this Scheme shall be made only by way of a Scheme Amendment Letter in accordance with Clause 18, and not by altering this document.
This Scheme is based on the standard EASE template (v1.0) available at ease.equitylist.co. The Company confirms that it has not modified the standard template text, except to fill in blanks and bracketed terms. Any amendments to the Scheme after adoption are made only by way of a Scheme Amendment Letter in accordance with Clause 18.
Key Terms
| Administrator |
appointed by the Board, or the Board acting in the absence of a named appointment. The Administrator is Board-appointed and Board-removable. See Clause 16. |
| ESOP Pool |
[Pool size] Options (representing approximately [X]% of the fully diluted share capital as at the date of adoption). |
| Exercise Price |
₹[Exercise price] per Option, or as determined by the Administrator and specified in each Letter of Grant (not less than the face value of ₹[Face value] per Equity Share). See Clause 7. |
| Vesting Schedule |
Unless otherwise specified in the Letter of Grant: [N]-year vesting with a one (1) year cliff, followed by [vesting frequency] vesting. See Clause 6. |
| Exercise Period |
See Exercise Period table below for treatment of Vested and Unvested Options based on employment status. See Clause 9. |
Exercise Period — The treatment of Vested and Unvested Options based on employment status:
| Scenario |
Vested Options |
Unvested Options |
| Continuing Employment |
May be Exercised at any time. No time limit while employed. |
Continue to Vest per the Vesting Schedule. |
Resignation (employee initiated; not for cause) |
May be Exercised within three (3) years from last working date. Lapse thereafter. |
Cancelled immediately and return to the pool. |
| Termination for Cause |
Cancelled immediately. |
Cancelled immediately and return to the pool. |
Termination without cause (employer initiated) |
May be Exercised within five (5) years from last working date. Lapse thereafter. |
Cancelled immediately and return to the pool. |
| Death |
May be Exercised by nominee(s) / legal heir(s) within five (5) years from date of death. |
Vest immediately. Exercisable by nominee(s) / legal heir(s) within five (5) years. |
| Permanent Disability |
May be Exercised within five (5) years from date of certified Disability. |
Vest immediately. Exercisable within five (5) years. |
See Clause 9 for additional provisions relating to Exercise Period.
Clause 1 — Definitions
In this Scheme, unless the context otherwise requires:
| “Act” |
The Companies Act, 2013, including all rules, regulations, and notifications issued thereunder, as amended. |
| “Board” |
The board of directors of the Company, as constituted from time to time. |
| “Cause” |
Any act proven to be: (i) wilful failure to perform duties; (ii) dishonesty, fraud, or criminal act; (iii) gross negligence adversely affecting the Company; (iv) sexual harassment under the POSH Act, 2013; (v) disclosure of confidential information; or (vi) abandonment of employment (unauthorised absence exceeding 30 consecutive days). |
| “Date of Grant” |
The date on which an Option is granted, as specified in the Letter of Grant. |
| “Disability” |
A permanent condition rendering the Employee unable to engage in any substantial gainful activity, as certified by a Company-approved medical practitioner. |
| “Eligible Employee” |
An Employee nominated by the Administrator for the grant of Options per Clause 3. |
| “Employee” |
(i) A permanent employee of any Group Company; or (ii) a Director (excluding Independent Directors); but excludes (subject to the proviso in Clause 3) Promoters and Directors holding >10% of outstanding Equity Shares. See Clause 3. |
| “Equity Shares” |
Equity shares of the Company of face value ₹[Face value] each. |
| “Exercise” |
Subscribing to Equity Shares underlying Vested Options by submitting an Exercise Application and paying the Aggregate Exercise Cost (Exercise Price × number of Options Exercised). |
| “Exercise Price” |
The price per Option as set out in the Key Terms above or as specified in the Letter of Grant. |
| “FMV” |
Fair Market Value of an Equity Share, as determined by a registered valuer, or by a merchant banker for tax purposes on Exercise, in accordance with the Act and the Income-tax Rules, 1962, or any rules replacing them, as amended from time to time. |
| “Group Company” |
The Company and any subsidiary (Section 2(87) of the Act) or holding company thereof. |
| “Letter of Grant” |
The letter issued to an Eligible Employee specifying the number of Options, Vesting Schedule, Exercise Price, and other grant terms. |
| “Liquidity Event” |
(i) Sale of ≥50% of the Company’s share capital; (ii) merger or reorganisation transferring >50% voting power; (iii) sale of all or substantially all assets; (iv) filing for listing on a recognised stock exchange; or (v) any other event so determined by the Board. |
| “Option” |
A right granted to an Eligible Employee to subscribe to one (1) Equity Share at the Exercise Price, subject to this Scheme, any applicable Scheme Amendment Letter(s), and the Letter of Grant. |
| “Participant” |
An Eligible Employee who has been granted and has accepted Options under this Scheme. |
| “Scheme Amendment Letter” or “SAL” |
A letter executed by the Company in accordance with Clause 18 that amends or supplements this Scheme. Where the context so requires, references to “this Scheme” include the Scheme as amended by any applicable Scheme Amendment Letter(s). |
| “Vesting” |
The process by which a Participant becomes entitled to Exercise granted Options, per the Vesting Schedule in the Letter of Grant. |
Words in the singular include the plural and vice versa. Clause headings are for reference only. References to any statute include amendments thereto.
Clause 2 — Objective
This Scheme enables the Company to attract, retain and motivate talented Employees by providing them an opportunity to participate in ownership, aligning their interests with shareholders and creating long-term wealth through shared value creation.
Clause 3 — Eligibility
(a)
Options may be granted to Eligible Employees of the Company and its Group Companies. The Administrator shall determine the specific Employees and the number of Options to be granted to each.
(b)
The following persons are not eligible:
(i)Promoters or persons belonging to the Promoter group;
(ii)Directors holding >10% of outstanding Equity Shares (directly or indirectly); and
(iii)Independent Directors (Section 149(6) of the Act).
Proviso: If the Company is a DPIIT-recognised startup, the Board may permit Promoters to be eligible for a period of ten (10) years from incorporation, subject to Applicable Law.
Clause 4 — Pool Size
(a)
The total Options available under this Scheme shall be as specified in the Key Terms above. Each Option confers a right to subscribe for one (1) Equity Share.
(b)
Options that lapse, are forfeited, cancelled, or expire unexercised shall return to the pool and become available for fresh grant.
Clause 5 — Grant of Options
(a)
The Administrator may grant Options from time to time via a Letter of Grant, which shall specify: (i) number of Options; (ii) Vesting Schedule; (iii) Exercise Price; (iv) performance conditions, if any; and (v) such other terms as the Administrator may determine.
(b)
A grant must be accepted within such time as the Administrator prescribes. Upon acceptance, the Employee becomes a Participant. Unaccepted grants shall lapse unless the Administrator waives the delay.
(c)
A grant automatically lapses if the Company is wound up prior to acceptance.
Clause 6 — Vesting
(a)
There shall be a minimum period of one (1) year between the Date of Grant and first Vesting, as required under Applicable Law.
(b)
The default Vesting Schedule is as specified in the Key Terms above. The Administrator may specify a different schedule in the Letter of Grant for any Participant or class of Participants, provided the minimum one (1) year gap is maintained.
(c)
Vesting is conditional upon continued employment and such performance conditions as may be specified in the Letter of Grant.
(d)
The Administrator may accelerate Vesting in defined circumstances (including death or Disability). Acceleration upon a Liquidity Event or other extraordinary circumstances requires Board approval.
Clause 7 — Exercise Price
(a)
The Exercise Price shall be as specified in the Key Terms above, or as otherwise determined by the Administrator and specified in the Letter of Grant.
(b)
The Exercise Price shall not be less than the face value of the Equity Shares.
Clause 8 — Exercise of Options and Allotment
(a)
A Participant may Exercise Vested Options by submitting an Exercise Application in such form as the Administrator prescribes, together with payment of the Aggregate Exercise Cost and applicable taxes.
(b)
Payment shall be made by electronic transfer, cheque, or such other mode as approved by the Administrator.
(c)
Upon valid Exercise, the Company shall allot Equity Shares within the time prescribed under Applicable Law. Shares so allotted shall rank pari passu with existing equity shares.
(d)
Options not Exercised within the applicable Exercise Period, or expressly refused, shall lapse and return to the pool for fresh grant.
Clause 9 — Exercise Period
(a)
The treatment of Vested and Unvested Options based on employment status is set out in the Exercise Period table in the Key Terms section above.
(b)
The Administrator determines whether an act constitutes Cause. An affected Participant may escalate to the Board within thirty (30) days; the Board’s decision on escalation is final and binding.
(c)
On death, nominee(s)/legal heir(s) must produce requisite documents within one (1) year (or such extended time as the Administrator permits), failing which the Options shall lapse.
(d)
For scenarios not covered above, the Administrator shall determine the treatment at its discretion.
Clause 10 — Non-Transferability of Options
(a)
Options are non-transferable and Exercisable only by the Participant, except on death (nominee(s)/legal heir(s) may Exercise per Clause 9). Options shall not be pledged, hypothecated, or alienated in any manner.
Clause 11 — Restrictions on Transfer of Shares
(a)
Equity Shares allotted upon Exercise shall be subject to all restrictions on transfer, lock-in, right of first refusal, tag-along, drag-along, buyback, repurchase, and other terms as set out in the Articles of Association and the Shareholders’ Agreement of the Company, each as in effect from time to time.
(b)
By accepting Options, the Participant acknowledges and agrees to be bound by all such restrictions, whether or not the Participant is a signatory to the Shareholders’ Agreement.
(c)
The Company shall have the right, but not the obligation, to require a Participant to sell Equity Shares — including on cessation of employment — pursuant to any buyback or repurchase right under the Articles of Association and/or the Shareholders’ Agreement, at the price and in the manner set out therein, as in effect from time to time.
Clause 12 — Adjustment for Corporate Actions
(a)
Upon any variation in capital structure (bonus issue, rights issue, stock split, consolidation, reorganisation, etc.), the Board shall make fair and reasonable adjustments to: (i) the number and kind of Options outstanding; (ii) the Exercise Price; and (iii) the total pool — to preserve the economic value of the Options. Fractions shall be rounded to the nearest whole number.
Clause 13 — Liquidity Event — Notice and Exercise Rights
(a)
If the Board approves a Liquidity Event, it shall provide at least thirty (30) days’ prior written notice to all Participants who hold Vested Options, during which period Participants may Exercise such Vested Options before consummation of the Liquidity Event.
(b)
Participants holding Equity Shares (pursuant to Exercise of Options) shall be subject to drag-along rights as set out in Clause 11 and the Shareholders’ Agreement. The Participant shall be bound by the Board’s determination of price and transfer terms in connection with such drag-along.
Clause 14 — Tax
(a)
All tax obligations arising from the grant, Vesting, Exercise, or disposal of Options and Equity Shares are the sole responsibility of the Participant. The Company may deduct or withhold taxes as required under Applicable Law and may require satisfactory tax arrangements before allotting shares.
Clause 15 — Confidentiality
(a)
Participants shall keep all grant details (number of Options, Exercise Price, Vesting Schedule) strictly confidential. Breach may result in cancellation of Options (Vested or Unvested) at the Administrator’s discretion.
Clause 16 — Administration
(a)
This Scheme shall be administered by the Administrator specified in the Key Terms above. The Board appoints and may remove or replace the Administrator at any time.
(b)
The Administrator has full authority to interpret this Scheme, resolve disputes, and make all administrative determinations. Such determinations are final and binding, except where Board review is expressly provided (including under Clause 9(b)).
(c)
No member of the Board or the Administrator shall be personally liable for any good-faith decision under this Scheme.
Clause 17 — Power of Attorney
(a)
Each Participant shall, upon acceptance, deposit with the Company a duly executed irrevocable power of attorney authorising the Company to execute transfers of Equity Shares in connection with a Liquidity Event, drag-along under Clause 11, any buyback or repurchase of Shares under Clause 11, or any obligation under this Scheme. Failure to deposit the power of attorney within such time as prescribed by the Administrator may, at the Administrator’s discretion, result in the grant being treated as unaccepted.
Clause 18 — Amendment and Termination
(a)
This Scheme may be amended or terminated only by way of a Scheme Amendment Letter executed by the Company (acting through its Board). The Scheme shall at all times be read together with all Scheme Amendment Letters. No amendment shall be inconsistent with the Company’s Articles of Association or any Shareholders’ Agreement, except to the extent those documents have themselves been amended. Any consent, approval or shareholder resolution required under Applicable Law, the Articles or any Shareholders’ Agreement in relation to an amendment shall be obtained and recorded in the relevant Scheme Amendment Letter.
(b)
Material amendments require a special resolution of the shareholders, with evidence of shareholder approval. Material amendments include, without limitation: (i) increasing the ESOP pool size; (ii) changing eligibility criteria for the grant of Options; (iii) modifying the Exercise Period table in any way; (iv) modifying the Exercise Price; (v) changing the vesting cliff or default vesting schedule; (vi) altering Participant rights in a manner detrimental to existing Participants; (vii) changing the governing law or arbitration seat; and (viii) any change required by a statutory amendment to the Act or related rules. Non-material amendments may be made by Board resolution where a shareholder resolution is not required under Applicable Law or the Company’s Articles or Shareholders’ Agreement. Non-material amendments include, without limitation: (i) updating the Administrator name or designation; (ii) clarifying an operational or administrative process; (iii) adding a Group Company to the scope of the Scheme; (iv) correcting a typographical error or placeholder; and (v) any change that is explicitly within the Board’s existing discretion under this Scheme.
(c)
No Scheme Amendment Letter may adversely affect the rights of existing Participants in respect of Options already granted under this Scheme, unless (i) shareholder approval has been obtained where Applicable Law, the Articles or any Shareholders’ Agreement so require, and (ii) each affected Participant has consented in writing. If there is any conflict between this Scheme and a valid Scheme Amendment Letter, the Scheme Amendment Letter shall prevail for the specific matter it amends or supplements. This Clause 18 does not limit any powers of shareholders under Applicable Law, this Scheme or any Scheme Amendment Letter.
(d)
Options that lapse, are forfeited, cancelled or expire with the passage of time shall be dealt with in accordance with Clause 4 of this Scheme (or any successor clause dealing with the treatment of such Options).
(e)
The Company shall ensure that a consolidated version of this Scheme, incorporating all Scheme Amendment Letters and the current Exercise Period table, is maintained for reference. The Scheme text may be reformatted or re-paginated to align with this consolidation, without changing its substance.
(f)
The Administrator shall compile and make available such consolidated Scheme and Scheme Amendment Letters for all purposes under this Scheme.
Clause 19 — Disclaimer of Liability
(a)
Participation is voluntary and not a guarantee of financial return. Fluctuation risk in share value is borne solely by the Participant. The grant of Options does not form part of employment compensation and does not create any right to continued employment.
Clause 20 — Governing Law and Disputes
(a)
This Scheme is governed by the laws of India.
(b)
Disputes shall be referred to arbitration by a sole arbitrator appointed by the Board, under the Arbitration and Conciliation Act, 1996. Seat: [City]. Language: English.
(c)
Subject to Clause 20(b), courts at [City] shall have exclusive jurisdiction.
* * *
Approvals
Date of Shareholders’ Approval:
For and on behalf of [Company name]